-
March 23, 2017 Lupin Receives FDA Approval for Generic TOBI® Inhalation Solution
-
March 16, 2017 Lupin launches Generic Minastrin® 24 Fe chewable tablets in the US
-
March 9, 2017 Lupin launches Hydrocodone Bitartrate and Acetaminophen tablets in the US
-
March 7, 2017 Lupin launches Generic Paxil CR® tablets in the US
-
March 3, 2017 Lupin Receives FDA Approval for Generic Suprep® Bowel Prep Kit
-
March 2, 2017 Lupin Launches Generic Pristiq® Tablets in the US
-
March 1, 2017 Lupin Launches Generic Temovate® Clobetasol Propionate Scalp Application in the US
-
February 28, 2017 Lupin Receives FDA Approval for Generic Percocet® Tablets
-
February 27, 2017 Astellas and Lupin’s subsidiary Kyowa enter into an Agreement
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications